Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000932440-06-000541
Filing Date
2006-11-29
Accepted
2006-11-29 16:54:14
Documents
2
Period of Report
2006-11-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 5713
2 POWER OF ATTORNEY exhibit24-1_1149928.txt EX-24 3472
  Complete submission text file 0000932440-06-000541.txt   12173
Mailing Address 1220 GLENMORE DRIVE APOPKA FL 32712
Business Address 1220 GLENMORE DRIVE APOPKA FL 32712 407-880-2213
SHEFFIELD PHARMACEUTICALS INC (Issuer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 6770 Blank Checks

Mailing Address 430 PARK AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address 212-756-1562
Holman Wayne George (Reporting) CIK: 0001357605 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-12584 | Film No.: 061245927

Mailing Address 430 PARK AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address 430 PARK AVENUE, 12TH FLOOR NEW YORK NY 10022 212-756-1562
Ridgeback Capital Management LLC (Reporting) CIK: 0001357610 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-12584 | Film No.: 061245928

Mailing Address 430 PARK AVENUE 12TH FLOOR NEW YORK NY 10022
Business Address 430 PARK AVENUE 12TH FLOOR NEW YORK NY 10022 212-624-2567
Ridgeback Capital Investments Ltd. (Reporting) CIK: 0001358916 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-12584 | Film No.: 061245929